© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Building a Better Future
Posted 30th April 2020

Building a Better Future

There are few things in the world that can unite people quite like the universal burden of cancer and neurodegenerative diseases. A company located on the German border near the Czech Republic remains wholly dedicated to the ongoing fight to erase these diseases forever. After its recognition as a Leading Innovator in AI-Based Personalised Medicine Solutions 2020 – Germany, we shine a light on the work of BioVariance GmbH in this latest issue of Acquisition International.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Building a Better Future

BioVariance GmbH

There are few things in the world that can unite people quite like the universal burden of cancer and neurodegenerative diseases. A company located on the German border near the Czech Republic remains wholly dedicated to the ongoing fight to erase these diseases forever. After its recognition as a Leading Innovator in AI-Based Personalised Medicine Solutions 2020 – Germany, we shine a light on the work of BioVariance GmbH in this latest issue of Acquisition International.

When someone becomes sick, physicians usually draw on the common range of medicines and pills. Paracetamol, Ibuprofen and other household drug brands will help most people overcome a headache or other minor aches. However, for the severe cases, such as cancer or neurodegenerative diseases, there is a rapid and strong need to find the right type of medicine that patients will potentially respond to. It is this need that the team of BioVariance have sought to address, by analysing complex biomedical and genetic data from patients to ensure they receive a personalized treatment. Founded in 2013 and headquartered in Waldsassen, Germany, BioVariance’s multidisciplinary team consisting of software developers, biologists and data scientists develops innovative AI solutions for precision medicine in the healthcare, biotech and pharmaceutical sectors.

In cooperation with oncological clinics, laboratories, pharmaceutical companies and physicians all over the country, BioVariance offers long-term monitoring of molecular changes in patients to predict the effectiveness, side effects and drug interactions of specific medications. The company also helps to determine the optimal medication and dosage for each patient individually. Achieving this level of information is not easy at all and requires the combination of profound knowledge with state-of-the-art automatization and parallelization techniques, machine learning and mathematical algorithms to analyse complex biomedical data.

The vision of BioVariance is shared by people all over the world: the eradication of complex diseases and the increase of survival rates by making cancer and neurodegenerative diseases as treatable as the common cold. The company totally focuses on the improvement of patient’s health and quality of life by analysing and interpreting his biomedical data. Working at the junction of some of the most modern technologies, BioVariance represents the fusion of molecular genetics, big data and artificial intelligence that enables personalized care as never before.

For the multidisciplinary team this work is more than just a job. The work culture is characterised by technological advancement, insatiable curiosity and open-mindedness, based on five core values: integrity, responsibility, collaboration, professionalism and innovation. Rather than seeking to maximise profits, BioVariance values patient care above everything else and strives every day to save human lives.

BioVariance offers its services to pharmaceutical companies, physicians and patients themselves. Pharma companies are supported in the analysis of complex molecular biological and biomedical data by using state-of-the-art techniques to identify fundamental correlations across all biological levels, from DNA to metabolites. The application of machine learning, neuronal networks, mathematical algorithms and statistical methods in combination with existing clinical data ensure the high quality of the analytical results.

All results are validated by searching comprehensive medical literature, with the patient’s data being compared with data already existing in the fields of biology, pharmacology and medicine. By understanding, identifying and evaluating biological markers and molecular signatures, pharma companies can be prepared more than ever to develop new effective drugs and personalized treatments.

These personalized applications are then transferred to the other two focus areas of BioVariance: the physician and the patient. For physicians, the company aims to provide more efficient options when a personalized treatment is required. The goal of personalized medicine is to determine the most suitable medication in the optimal dosage for each patient individually. This is rarely easy, however. Doctors and physicians all over the world depend on correct medical diagnoses that consider the personal characteristics and circumstances of a patient’s life, as well as their genetic and molecular biological background. Comprehensive and accurate genetic analyses can ensure that physicians prescribe only the most effective treatment and avoid wrong prescriptions which lead to strong side effects in the worst case. This is where BioVariance comes in.

Analysing individual genetic characteristics and then comparing them with global literature can help physicians and hospitals optimize therapy and adapt it to the specific needs of the patient. Attending physicians and hospitals all over the country and worldwide can access comprehensive reports that contain information about the patient’s diagnosis, current therapies, previous medications and the results of BioVariance’s genetic analysis. Additionally, information about possible side effects and drug interactions that may occur during certain therapies support the selection of an effective treatment.

Considering genetic impacts, physicians and hospitals can avoid non-responsive therapies, eliminate potential side effects, raise survival rates, increase patients’ satisfaction and save valuable time in the treatment process. The genetic fingerprint of an individual helps determine how it may react to a certain treatment or medication. By tailoring therapies, BioVariance helps alleviate patients’ concerns by ensuring their therapy is designed specifically for them.

A challenge of any therapy is the independent intake of medication; another factor the team of BioVariance has carefully dealt with. The company’s mobile app Pillbox reminds patients to take their medication at a specific time and in the correct dosage. Further, the app documents the therapeutic process, symptoms and side effects to inform the attending physician whether an exchange of medication or an adjustment of dosage is necessary. Being a technical marvel, Pillbox also comes with a diary function, an integrated barcode scanner for an easy addition of drugs to the treatment plan and a chat function allowing direct communication between patient and physician.

Cancer and neurodegenerative diseases are undoubtedly some of the greatest medical concerns of our time, but some that the community is actively working towards addressing every single day. For today’s diagnosed patients the wonders of modern medicine and technology represent more than just a chance. It represents hope. Hope for a brighter future, where families are no longer torn apart by death and disease. Hope that, one day, these diseases will be nothing more than a distant memory.

Contact Details:
Company: BioVariance GmbH
Contact: Dr Josef Scheiber
Website: www.biovariance.com

Categories: Innovation, Leadership


You Might Also Like
Read Full PostRead - Eye Icon
Changing the Appearance of Your Business: A Guide
News
28/01/2021Changing the Appearance of Your Business: A Guide

With the new year in full swing and with the long-awaited vaccine on the horizon, it is safe to say that life as we know it will be upon us in no time! Many people use this time of year to make changes to certain aspects of their lives, and this is undoubtedly

Read Full PostRead - Eye Icon
Financing Gap For Female Entrepreneurs Widens By 78% Since The Rose Review in 2019
Finance
25/04/2024Financing Gap For Female Entrepreneurs Widens By 78% Since The Rose Review in 2019

The financing gap between men and women for government-backed Start Up Loans has widened by 78% since the Alison Rose Review was published in 2019 - an independent review of female entrepreneurship in the UK commissioned by the Treasury.

Read Full PostRead - Eye Icon
CEO of the Year, Germany
Innovation
29/02/2016CEO of the Year, Germany

Linguatec develops and markets leading edge language technology solutions for Machine Translation, Automatic Speech Recognition and Speech Synthesis.

Read Full PostRead - Eye Icon
What A Software Mortgage Broker Setup Should Do For a Growing Firm
Technology
20/08/2026What A Software Mortgage Broker Setup Should Do For a Growing Firm

Growth creates pressure in places that a small advice firm may once have managed informally. More enquiries mean more handovers, more outstanding documents and a greater need for consistent supervision. A spreadsheet or individual inbox can appear adequate unt

Read Full PostRead - Eye Icon
When Is the Right Time to Seek IT Consulting Services?
News
19/11/2021When Is the Right Time to Seek IT Consulting Services?

The rise of the internet and the development of information technology (IT) have enabled businesses to promote their operations from local to international markets. This involves using computer tools and programs to connect with customers, workers, and other s

Read Full PostRead - Eye Icon
HAYSTACKID Acquisition of FLEX Discovery Transaction
Innovation
29/02/2016HAYSTACKID Acquisition of FLEX Discovery Transaction

HAYSTACKID is an international end-to-end eDiscovery and forensics services and solutions provider.

Read Full PostRead - Eye Icon
Investcorp Expands Real Estate Portfolio with Acquisition of Four Residential Properties
Finance
25/03/2015Investcorp Expands Real Estate Portfolio with Acquisition of Four Residential Properties

Investcorp, a leading provider and manager of alternative investment products, today announced that its U.S.-based real estate arm, through separate transactions, has acquired a portfolio of residential properties in the metropolitan areas of Washington, D.C.,

Read Full PostRead - Eye Icon
Clifford Chance Advise Perceva Acquisition of Vanity Fair brand
M&A
30/07/2015Clifford Chance Advise Perceva Acquisition of Vanity Fair brand

Clifford Chance Advise Perceva Acquisition of Vanity Fair brand

Read Full PostRead - Eye Icon
How Fleet Insurance Can Enhance Risk Equations For SMEs?
News
15/06/2022How Fleet Insurance Can Enhance Risk Equations For SMEs?

Fleet insurance is insurance coverage for a business’s vehicles. Instead of getting insurance for individual cars, you can get collective insurance for the fleet. It will save you the hassle of monitoring each vehicle’s separate car insurance policy and re



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow